Stock PRDA PT PRODIA WIDYAHUSADA TBK
Add to a list
To use this feature you must be a member
Log inSign up

Ratings PT Prodia Widyahusada Tbk

Equities

PRDA

ID1000138001

End-of-day quote INDONESIA S.E.
Other stock markets
 06:00:00 2024-04-29 pm EDT 		5-day change 1st Jan Change
3,280 IDR +0.61% Intraday chart for PT Prodia Widyahusada Tbk -5.48% -39.26%
Mar. 08 PT Prodia Widyahusada Tbk Reports Earnings Results for the Full Year Ended December 31, 2023 CI
2023 PT Prodia Widyahusada Tbk Reports Earnings Results for the Nine Months Ended September 30, 2023 CI

Summary

  • The company has strong fundamentals. More than 70% of companies have a lower mix of growth, profitability, debt and visibility.

Strengths

  • Thanks to a sound financial situation, the firm has significant leeway for investment.
  • The equity is one of the most attractive in the market with regard to earnings multiple-based valuation.
  • The company has attractive valuation levels with a low EV/sales ratio compared with its peers.
  • The company is one of the best yield companies with high dividend expectations.
  • Analysts covering this company mostly recommend stock overweighting or purchase.
  • The difference between current prices and the average target price is rather important and implies a significant appreciation potential for the stock.

Weaknesses

  • For the last twelve months, the trend in sales revisions has been clearly going down, which emphasizes downgraded expectations from the analysts.
  • The sales outlook for the group was lowered in the last twelve months. This change in forecast points out a decline in activity as well as pessimistic analyses of the company.
  • For the past year, analysts have significantly revised downwards their profit estimates.
  • For the last twelve months, the analysts covering the company have given a bearish overview of EPS estimates, resulting in frequent downward revisions.
  • Over the past four months, analysts' average price target has been revised downwards significantly.
  • The average consensus view of analysts covering the stock has deteriorated over the past four months.
  • The company's earnings releases usually do not meet expectations.

Ratings chart - Surperformance

Sector: Healthcare Facilities & Services

1st Jan change Capi. Investor Rating ESG Refinitiv
PT PRODIA WIDYAHUSADA TBK Stock PT Prodia Widyahusada Tbk
-39.26% 190M -
SONIC HEALTHCARE LIMITED Stock Sonic Healthcare Limited
-19.14% 8.22B
B+
RADNET, INC. Stock RadNet, Inc.
+46.76% 3.73B
C+
SYNLAB AG Stock SYNLAB AG
-8.06% 2.46B -
GUANGZHOU KINGMED DIAGNOSTICS GROUP CO., LTD. Stock Guangzhou Kingmed Diagnostics Group Co., Ltd.
-38.71% 2.46B
B-
DR. LAL PATHLABS LIMITED Stock Dr. Lal PathLabs Limited
-8.84% 2.36B
B-
NEOGENOMICS, INC. Stock NeoGenomics, Inc.
-11.80% 1.78B
C-
FLEURY S.A. Stock Fleury S.A.
-19.01% 1.52B
A-
DIAN DIAGNOSTICS GROUP CO.,LTD. Stock Dian Diagnostics Group Co.,Ltd.
-40.78% 1.21B
C+
METROPOLIS HEALTHCARE LIMITED Stock Metropolis Healthcare Limited
+8.32% 1.12B
B+
Investor Rating
Trading Rating
ESG Refinitiv
-

Financials

Sales growth
Earnings Growth
EBITDA / Sales
Profitability
Finances

Valuation

P/E ratio
EV / Sales
Price to Book
Price to Free Cash Flow
Yield

Momentum

1 year Revenue revision
4 months Revenue revision
7 days Revenue revision
1 year EPS revision
4 months EPS revision

Consensus

Analyst Opinion
Potential Price Target
4m Target Price Revision
4m Revision of opinion
12m Revision of opinion

Business Predictability

Analyst Coverage
Divergence of Estimates
Divergence of analysts' opinions
Divergence of Target Price
Earnings quality

Technical analysis

ST Timing
MT Timing
LT Timing
RSI
Bollinger Spread
Unusual volumes
  1. Stock Market
  2. Equities
  3. PRDA Stock
  4. Ratings PT Prodia Widyahusada Tbk